Herbal extract & diabetes
Phase 2
Recruiting
- Conditions
- Type 2 diebetes.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20110314006065N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with type 2 diabetes mellitus
Age 30 to 70 years
Exclusion Criteria
Insulin or liraglutide injection
People under 30 and over 70
Chronic cardiovascular disease, major depression, chronic liver and kidney disease, chronic thyroid disorders and malignancies including cancer
Neuroleptics, medical Herbs or herbs to control blood sugar over the past 6 months
Patients being treated with a special diet such as vegetarian diets or a specific exercise program.
People with food or seasonal allergies
Pregnant and lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.
- Secondary Outcome Measures
Name Time Method Total cholesterol. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;Low-density lipoprotein. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;High-density lipoprotein. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;Triglyceride. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer.;HbA1c. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Chromatography.